Akero Therapeutics Inc. (AKRO) NASDAQ

$8.18 -0.05 (-0.61%)

Market Cap: $288.24M

As of 05/25/22 04:00 PM EDT. Market closed.

(AKRO)

Akero Therapeutics Inc. (AKRO) NASDAQ

$8.18 -0.05 (-0.61%)

Market Cap: $288.24M

As of 05/25/22 04:00 PM EDT. Market closed.

Akero Therapeutics is a clinical-stage cardio-metabolic company developing transformational treatments for non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Akero's lead product candidate, EFX, an engineered Fc-FGF21 fusion protein, is currently being evaluated in Phase 2 clinical trials as a potential treatment for NASH. Akero is headquartered in South San ... read more

Akero Therapeutics is a clinical-stage cardio-metabolic company developing transformational treatments for non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Akero's lead product candidate, EFX, an engineered Fc-FGF21 fusion protein, is currently being evaluated in Phase 2 clinical trials as a potential treatment for NASH. Akero is headquartered in South San Francisco. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
601 Gateway Boulevard, Suite 350, California, South San Francisco, 94080.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
22
Address
601 Gateway Boulevard, Suite 350, California, South San Francisco, 94080.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$8.23
Previous Close
$8.23
Days Range
$8.10 - $8.56
52 week range
$7.88 - $30.53
Volume
176,158
Avg. Volume (30 days)
303,056
Market Cap
$288.24M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
35,022,935
Open
$8.23
Previous Close
$8.23
Days Range
$8.10 - $8.56
52 week range
$7.88 - $30.53
Volume
176,158
Avg. Volume (30 days)
303,056
Market Cap
$288.24M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
35,022,935

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR AKERO THERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Cheng Andrew President & CEO Mar 01, 2022 Option Exercise $0.62 10,000 6,150 318,996 Mar 02, 2022, 08:40 PM
Cheng Andrew President & CEO Mar 01, 2022 Sale $17.59 10,000 175,900 308,996 Mar 02, 2022, 08:40 PM
Cheng Andrew President & CEO Feb 01, 2022 Option Exercise $0.62 10,000 6,150 318,996 Feb 03, 2022, 07:12 PM
Cheng Andrew President & CEO Feb 01, 2022 Sale $17.56 10,000 175,600 308,996 Feb 03, 2022, 07:12 PM
White William Richard Chief Financial Officer Jan 14, 2022 Option Exercise $7.01 9,700 67,987 12,977 Jan 18, 2022, 09:48 PM
White William Richard Chief Financial Officer Jan 14, 2022 Sale $22.03 9,700 213,691 3,277 Jan 18, 2022, 09:48 PM
Cheng Andrew President & CEO Jan 10, 2022 Option Exercise $0.62 10,000 6,150 308,996 Jan 11, 2022, 09:40 PM
Cheng Andrew President & CEO Jan 10, 2021 Sale $19.55 10,000 195,500 298,996 Jan 11, 2022, 09:40 PM
Young Jonathan Chief Operating Officer Jan 07, 2022 Option Exercise $0.62 27,744 17,063 163,254 Jan 11, 2022, 04:40 PM
Cheng Andrew President & CEO Jan 03, 2022 Option Exercise $0.62 53,000 32,595 308,996 Jan 04, 2022, 09:21 PM
White William Richard Chief Financial Officer Dec 21, 2021 Option Exercise $7.01 100 701 3,377 Dec 23, 2021, 09:03 PM
White William Richard Chief Financial Officer Dec 21, 2021 Sale $22.00 100 2,200 3,277 Dec 23, 2021, 09:03 PM
White William Richard Chief Financial Officer Dec 17, 2021 Option Exercise $7.01 3,200 22,429 6,477 Dec 20, 2021, 04:54 PM
White William Richard Chief Financial Officer Dec 17, 2021 Sale $22.04 3,200 70,528 3,277 Dec 20, 2021, 04:54 PM
Cheng Andrew President & CEO Dec 02, 2021 Sale $20.18 17,500 353,150 255,996 Dec 03, 2021, 05:20 PM
Young Jonathan Chief Operating Officer Nov 03, 2021 Sale $24.27 18,780 455,791 141,730 Nov 05, 2021, 04:17 PM
Young Jonathan Chief Operating Officer Nov 04, 2021 Sale $24.33 6,220 151,333 135,510 Nov 05, 2021, 04:17 PM
Cheng Andrew President & CEO Nov 02, 2021 Sale $22.57 17,500 394,975 273,496 Nov 03, 2021, 04:16 PM
White William Richard Chief Financial Officer Nov 01, 2021 Option Exercise $7.01 6,500 45,558 9,777 Nov 03, 2021, 04:15 PM
White William Richard Chief Financial Officer Nov 01, 2021 Sale $22.24 6,500 144,560 3,277 Nov 03, 2021, 04:15 PM
Yale Catriona Chief Development Officer Oct 15, 2021 Sale $21.59 12,500 269,826 121,021 Oct 18, 2021, 04:21 PM
Cheng Andrew President & CEO Oct 04, 2021 Sale $21.54 17,500 376,950 290,996 Oct 05, 2021, 04:11 PM
White William Richard Chief Financial Officer Oct 01, 2021 Option Exercise $7.01 6,500 45,558 9,777 Oct 05, 2021, 04:10 PM
White William Richard Chief Financial Officer Oct 01, 2021 Sale $22.06 6,500 143,367 3,277 Oct 05, 2021, 04:10 PM
Yale Catriona Chief Development Officer Sep 15, 2021 Sale $24.69 12,500 308,605 135,421 Sep 17, 2021, 04:05 PM
Young Jonathan Chief Operating Officer Sep 01, 2021 Sale $24.04 12,500 300,500 160,510 Sep 03, 2021, 04:38 PM
White William Richard Chief Financial Officer Sep 01, 2021 Option Exercise $7.01 8,559 59,990 11,836 Sep 03, 2021, 04:38 PM
White William Richard Chief Financial Officer Sep 01, 2021 Sale $24.00 8,559 205,416 3,277 Sep 03, 2021, 04:38 PM
Cheng Andrew President & CEO Sep 02, 2021 Sale $23.89 17,500 418,075 308,496 Sep 03, 2021, 04:37 PM
Yale Catriona Chief Development Officer Aug 16, 2021 Sale $18.79 10,000 187,900 145,921 Aug 17, 2021, 09:15 PM
White William Richard Chief Financial Officer Aug 02, 2021 Option Exercise $7.01 4,441 31,127 7,718 Aug 04, 2021, 05:39 PM
White William Richard Chief Financial Officer Aug 02, 2021 Sale $22.03 4,441 97,835 3,277 Aug 04, 2021, 05:39 PM
Cheng Andrew President & CEO Aug 03, 2021 Sale $20.83 17,500 364,577 326,596 Aug 04, 2021, 05:38 PM
Yale Catriona Chief Development Officer Jul 15, 2021 Sale $20.90 10,000 209,044 155,921 Jul 19, 2021, 04:43 PM
Young Jonathan Chief Operating Officer Jul 15, 2021 Option Exercise $0.62 9,000 5,535 173,010 Jul 19, 2021, 04:43 PM
White William Richard Chief Financial Officer Jul 06, 2021 Option Exercise $7.01 6,500 45,558 9,777 Jul 08, 2021, 07:19 PM
White William Richard Chief Financial Officer Jul 06, 2021 Sale $24.52 6,500 159,380 3,277 Jul 08, 2021, 07:19 PM
Cheng Andrew President & CEO Jul 02, 2021 Sale $24.78 17,500 433,650 342,489 Jul 06, 2021, 05:52 PM
Bitterman Kevin Director Jun 01, 2021 Sale $26.28 17,489 459,611 0 Jun 03, 2021, 08:07 PM
Young Jonathan Chief Operating Officer Apr 01, 2021 Sale $28.75 3,055 87,828 170,120 Apr 05, 2021, 05:15 PM
White William Richard Chief Financial Officer Apr 01, 2021 Option Exercise $7.01 50,000 350,500 52,270 Apr 05, 2021, 05:14 PM
White William Richard Chief Financial Officer Apr 01, 2021 Sale $28.64 50,000 1,432,166 3,419 Apr 05, 2021, 05:14 PM
Young Jonathan Chief Operating Officer Mar 01, 2021 Sale $30.48 3,055 93,112 173,375 Mar 02, 2021, 05:56 PM
Young Jonathan Chief Operating Officer Feb 01, 2021 Sale $29.24 3,055 89,321 176,430 Feb 02, 2021, 04:08 PM
Cheng Andrew President & CEO Jan 07, 2021 Option Exercise $0.62 20,000 12,300 362,989 Jan 11, 2021, 07:57 PM
Young Jonathan Chief Operating Officer Jan 07, 2021 Option Exercise $0.62 7,500 4,613 189,285 Jan 11, 2021, 07:54 PM
Young Jonathan Chief Operating Officer Jan 08, 2021 Sale $28.12 10,000 281,200 179,285 Jan 11, 2021, 07:54 PM
Young Jonathan Chief Operating Officer Jan 04, 2021 Sale $25.29 3,060 77,399 181,885 Jan 06, 2021, 06:48 PM
Cheng Andrew President & CEO Dec 28, 2020 Option Exercise $0.62 7,480 4,638 342,989 Dec 29, 2020, 04:53 PM
Cheng Andrew President & CEO Dec 21, 2020 Option Exercise $0.62 10,500 6,510 335,509 Dec 23, 2020, 04:19 PM
Young Jonathan Chief Operating Officer Jun 30, 2020 Option Exercise $17.07 1,245 21,250 184,845 Dec 09, 2020, 08:53 PM
White William Richard Chief Financial Officer Jun 30, 2020 Option Exercise $17.07 1,245 21,250 2,270 Dec 09, 2020, 08:52 PM
Yale Catriona Chief Development Officer Jun 30, 2020 Option Exercise $17.07 1,245 21,250 164,914 Dec 09, 2020, 08:50 PM
Rolph Timothy Chief Scientific Officer Jun 30, 2020 Option Exercise $17.07 1,245 21,250 244,178 Dec 09, 2020, 08:49 PM
Cheng Andrew Chief Executive Officer Jun 30, 2020 Option Exercise $17.07 1,245 21,250 327,559 Dec 09, 2020, 08:47 PM
Bitterman Kevin Director Oct 09, 2020 Sale $28.93 13,000 376,090 11,780 Oct 14, 2020, 04:54 PM
Apple Tree Partners IV, L.P. 10% Owner Jul 10, 2020 Buy $36.00 415,000 14,940,000 5,830,203 Jul 14, 2020, 04:46 PM
Harrison Seth Loring Director Jul 10, 2020 Buy $36.00 415,000 14,940,000 5,830,203 Jul 14, 2020, 04:45 PM
Versant Venture Capital VI, L.P. 10% Owner Jan 08, 2020 Sale $19.80 22,368 442,886 2,863,468 Jul 10, 2020, 08:28 PM
Versant Venture Capital VI, L.P. 10% Owner Jan 07, 2020 Sale $20.05 14,162 283,948 2,885,836 Jul 10, 2020, 08:28 PM
Versant Venture Capital VI, L.P. 10% Owner Jan 09, 2020 Sale $20.21 16,527 334,011 2,846,941 Jul 10, 2020, 08:28 PM
Versant Venture Capital VI, L.P. 10% Owner Jan 06, 2020 Sale $19.54 53,392 1,043,102 2,948,422 Jul 10, 2020, 08:28 PM
Versant Venture Capital VI, L.P. 10% Owner Jan 03, 2020 Sale $19.21 3,200 61,485 2,953,490 Jul 10, 2020, 08:28 PM
Versant Venture Capital VI, L.P. 10% Owner Jan 02, 2020 Sale $20.36 15,852 322,685 3,645,633 Jul 10, 2020, 08:28 PM
venBio Global Strategic Fund II L.P. 10% Owner Jul 06, 2020 Sale $33.83 4,603 155,721 3,033,552 Jul 06, 2020, 07:00 PM
venBio Global Strategic Fund II L.P. 10% Owner Jul 02, 2020 Sale $33.63 3,800 127,805 3,038,155 Jul 06, 2020, 07:00 PM
venBio Global Strategic Fund II L.P. 10% Owner Jul 01, 2020 Sale $34.45 108,064 3,723,010 3,041,955 Jul 06, 2020, 07:00 PM
Graham G. Walmsley Director Mar 30, 2020 Option Exercise $19.97 2,168 43,295 2,168 Apr 01, 2020, 06:52 PM
Young Jonathan Chief Operating Officer Mar 13, 2020 Option Exercise $0.62 11,117 6,837 183,600 Mar 16, 2020, 05:51 PM
Rolph Timothy Chief Scientific Officer Mar 12, 2020 Option Exercise $0.61 50,024 30,515 242,933 Mar 13, 2020, 07:04 PM
venBio Global Strategic Fund II L.P. 10% Owner Mar 06, 2020 Sale $23.79 1,800 42,831 3,150,019 Mar 06, 2020, 05:23 PM
venBio Global Strategic Fund II L.P. 10% Owner Mar 05, 2020 Sale $23.53 8,500 200,011 3,151,819 Mar 06, 2020, 05:23 PM
venBio Global Strategic Fund II L.P. 10% Owner Mar 04, 2020 Sale $23.81 35,650 848,766 3,160,319 Mar 06, 2020, 05:23 PM
venBio Global Strategic Fund II L.P. 10% Owner Feb 28, 2020 Sale $21.30 5,100 108,652 3,212,667 Mar 03, 2020, 05:52 PM
venBio Global Strategic Fund II L.P. 10% Owner Mar 03, 2020 Sale $23.00 6,401 147,199 3,195,969 Mar 03, 2020, 05:52 PM
venBio Global Strategic Fund II L.P. 10% Owner Mar 02, 2020 Sale $23.06 10,297 237,459 3,202,370 Mar 03, 2020, 05:52 PM
venBio Global Strategic Fund II L.P. 10% Owner Feb 27, 2020 Sale $22.54 1,781 40,144 3,227,767 Feb 27, 2020, 07:51 PM
venBio Global Strategic Fund II L.P. 10% Owner Feb 26, 2020 Sale $22.44 2,523 56,615 3,229,548 Feb 27, 2020, 07:51 PM
venBio Global Strategic Fund II L.P. 10% Owner Feb 25, 2020 Sale $23.67 1,600 37,876 3,232,071 Feb 27, 2020, 07:51 PM
venBio Global Strategic Fund II L.P. 10% Owner Feb 11, 2020 Sale $27.05 2,184 59,068 3,233,677 Feb 12, 2020, 05:56 PM
venBio Global Strategic Fund II L.P. 10% Owner Feb 10, 2020 Sale $27.08 7,836 212,168 3,225,861 Feb 12, 2020, 05:56 PM
venBio Global Strategic Fund II L.P. 10% Owner Feb 12, 2020 Sale $27.14 6 163 3,233,671 Feb 12, 2020, 05:56 PM
venBio Global Strategic Fund II L.P. 10% Owner Feb 06, 2020 Sale $27.03 6,102 164,955 3,233,697 Feb 10, 2020, 05:47 PM
venBio Global Strategic Fund II L.P. 10% Owner Feb 05, 2020 Sale $25.99 28,608 743,548 3,239,799 Feb 06, 2020, 04:06 PM
venBio Global Strategic Fund II L.P. 10% Owner Feb 04, 2020 Sale $25.65 53,731 1,378,179 3,268,407 Feb 06, 2020, 04:06 PM
Versant Venture Capital VI, L.P. 10% Owner Jan 17, 2020 Sale $20.09 11,103 223,059 3,118,638 Jan 21, 2020, 09:57 PM
Versant Venture Capital VI, L.P. 10% Owner Jan 16, 2020 Sale $19.72 22,489 443,483 3,129,741 Jan 21, 2020, 09:57 PM
Versant Venture Capital VI, L.P. 10% Owner Jan 21, 2020 Sale $22.20 25,940 575,861 3,110,547 Jan 21, 2020, 09:57 PM
Versant Venture Capital VI, L.P. 10% Owner Jan 10, 2020 Sale $20.10 19,343 388,794 3,183,724 Jan 15, 2020, 09:53 PM
Versant Venture Capital VI, L.P. 10% Owner Jan 15, 2020 Sale $19.73 7,511 148,192 3,152,230 Jan 15, 2020, 09:53 PM
Versant Venture Capital VI, L.P. 10% Owner Jan 14, 2020 Sale $20.00 12,307 246,140 3,159,741 Jan 15, 2020, 09:53 PM
Versant Venture Capital VI, L.P. 10% Owner Jan 13, 2020 Sale $20.16 11,676 235,445 3,172,131 Jan 15, 2020, 09:53 PM
venBio Global Strategic Fund II L.P. 10% Owner Jan 13, 2020 Sale $20.23 494,000 9,993,620 3,322,138 Jan 14, 2020, 08:58 AM
Young Jonathan Chief Operating Officer Jan 10, 2020 Option Exercise $0.62 38,907 23,928 232,483 Jan 10, 2020, 07:39 PM
venBio Global Strategic Fund II L.P. 10% Owner Jan 08, 2020 Sale $19.86 15,677 311,355 3,816,138 Jan 10, 2020, 04:06 PM
venBio Global Strategic Fund II L.P. 10% Owner Jan 08, 2020 Sale $19.86 15,677 311,355 3,816,138 Jan 10, 2020, 04:06 PM
Versant Venture Capital VI, L.P. 10% Owner Jan 09, 2020 Sale $20.21 16,527 334,011 3,203,067 Jan 09, 2020, 08:11 PM
Versant Venture Capital VI, L.P. 10% Owner Jan 08, 2020 Sale $19.80 22,368 442,886 3,219,594 Jan 09, 2020, 08:11 PM
Versant Venture Capital VI, L.P. 10% Owner Jan 07, 2020 Sale $20.05 14,162 283,948 3,241,962 Jan 09, 2020, 08:11 PM
venBio Global Strategic Fund II L.P. 10% Owner Jan 07, 2020 Sale $20.17 31,000 625,149 3,831,815 Jan 08, 2020, 04:10 PM
venBio Global Strategic Fund II L.P. 10% Owner Jan 06, 2020 Sale $19.64 42,221 829,381 3,862,815 Jan 08, 2020, 04:10 PM
Versant Venture Capital VI, L.P. 10% Owner Jan 03, 2020 Sale $19.21 3,200 61,485 3,309,616 Jan 06, 2020, 08:59 PM
Versant Venture Capital VI, L.P. 10% Owner Jan 02, 2020 Sale $20.36 15,852 322,685 4,001,759 Jan 06, 2020, 08:59 PM
Versant Venture Capital VI, L.P. 10% Owner Jan 06, 2020 Sale $19.54 53,392 1,043,102 3,304,548 Jan 06, 2020, 08:59 PM
venBio Global Strategic Fund II L.P. 10% Owner Jan 03, 2020 Sale $19.30 12,498 241,214 3,905,036 Jan 06, 2020, 04:07 PM
venBio Global Strategic Fund II L.P. 10% Owner Jan 02, 2020 Sale $19.94 23,000 458,507 3,917,534 Jan 06, 2020, 04:07 PM
Cheng Andrew President & CEO Dec 31, 2019 Option Exercise $18.87 1,025 19,338 326,314 Jan 03, 2020, 06:16 PM
Yale Catriona Chief Development Officer Dec 31, 2019 Option Exercise $18.87 1,025 19,338 163,669 Jan 03, 2020, 06:16 PM
White William Richard Chief Financial Officer Dec 31, 2019 Option Exercise $18.87 1,025 19,338 1,025 Jan 03, 2020, 06:15 PM
venBio Global Strategic Fund II L.P. 10% Owner Dec 31, 2019 Sale $23.96 14,324 343,259 3,940,534 Jan 03, 2020, 12:00 AM
Versant Venture Capital VI, L.P. 10% Owner Dec 27, 2019 Sale $22.58 33,256 750,920 4,012,711 Dec 31, 2019, 07:11 PM
Versant Venture Capital VI, L.P. 10% Owner Dec 31, 2019 Sale $23.48 17,207 404,020 3,656,585 Dec 31, 2019, 07:11 PM
Versant Venture Capital VI, L.P. 10% Owner Dec 30, 2019 Sale $24.39 338,919 8,266,234 3,673,792 Dec 31, 2019, 07:11 PM
Versant Venture Capital VI, L.P. 10% Owner Dec 31, 2019 Sale $23.48 17,207 404,020 3,656,585 Dec 31, 2019, 06:05 PM
Versant Venture Capital VI, L.P. 10% Owner Dec 30, 2019 Sale $24.39 338,919 8,266,234 3,673,792 Dec 31, 2019, 06:05 PM
Versant Venture Capital VI, L.P. 10% Owner Dec 27, 2019 Sale $22.58 33,256 750,920 4,012,711 Dec 31, 2019, 06:05 PM
Versant Venture Capital VI, L.P. 10% Owner Dec 23, 2019 Sale $21.56 5,433 117,135 4,071,172 Dec 26, 2019, 08:59 PM
Versant Venture Capital VI, L.P. 10% Owner Dec 20, 2019 Sale $19.80 18,582 367,924 4,076,605 Dec 26, 2019, 08:59 PM
Versant Venture Capital VI, L.P. 10% Owner Dec 26, 2019 Sale $22.48 23,600 530,528 4,045,967 Dec 26, 2019, 08:59 PM
Versant Venture Capital VI, L.P. 10% Owner Dec 24, 2019 Sale $21.70 1,605 34,829 4,069,567 Dec 26, 2019, 08:59 PM
Versant Venture Capital VI, L.P. 10% Owner Dec 18, 2019 Sale $19.50 2,020 39,390 4,095,187 Dec 19, 2019, 09:30 PM
Versant Venture Capital VI, L.P. 10% Owner Dec 17, 2019 Sale $19.58 7,651 149,807 4,097,207 Dec 19, 2019, 09:30 PM
Bitterman Kevin Director Jun 24, 2019 Buy $16.00 270,000 4,320,000 505,099 Jun 25, 2019, 06:06 PM
Atlas Venture Fund XI, L.P. 10% Owner Jun 24, 2019 Buy $16.00 270,000 4,320,000 505,099 Jun 25, 2019, 06:06 PM
Royston Aaron Director Jun 24, 2019 Buy $16.00 250,000 4,000,000 250,000 Jun 25, 2019, 06:05 PM
Versant Venture Capital VI, L.P. 10% Owner Jun 24, 2019 Buy $16.00 400,000 6,400,000 4,104,858 Jun 25, 2019, 06:05 PM
Harrison Seth Loring Director Jun 24, 2019 Buy $16.00 900,000 14,400,000 5,415,203 Jun 25, 2019, 06:05 PM
Apple Tree Partners IV, L.P. 10% Owner Jun 24, 2019 Buy $16.00 900,000 14,400,000 5,415,203 Jun 25, 2019, 06:04 PM
venBio Global Strategic Fund II L.P. 10% Owner Jun 24, 2019 Buy $16.00 250,000 4,000,000 250,000 Jun 25, 2019, 09:20 AM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Cheng Andrew President & CEO 03/01/2022 6,150
Cheng Andrew President & CEO 03/01/2022 175,900
Cheng Andrew President & CEO 02/01/2022 6,150
Cheng Andrew President & CEO 02/01/2022 175,600
White William Richard Chief Financial Officer 01/14/2022 67,987
White William Richard Chief Financial Officer 01/14/2022 213,691
Cheng Andrew President & CEO 01/10/2022 6,150
Cheng Andrew President & CEO 01/10/2021 195,500
Young Jonathan Chief Operating Officer 01/07/2022 17,063
Cheng Andrew President & CEO 01/03/2022 32,595
White William Richard Chief Financial Officer 12/21/2021 701
White William Richard Chief Financial Officer 12/21/2021 2,200
White William Richard Chief Financial Officer 12/17/2021 22,429
White William Richard Chief Financial Officer 12/17/2021 70,528
Cheng Andrew President & CEO 12/02/2021 353,150
Young Jonathan Chief Operating Officer 11/03/2021 455,791
Young Jonathan Chief Operating Officer 11/04/2021 151,333
Cheng Andrew President & CEO 11/02/2021 394,975
White William Richard Chief Financial Officer 11/01/2021 45,558
White William Richard Chief Financial Officer 11/01/2021 144,560
Yale Catriona Chief Development Officer 10/15/2021 269,826
Cheng Andrew President & CEO 10/04/2021 376,950
White William Richard Chief Financial Officer 10/01/2021 45,558
White William Richard Chief Financial Officer 10/01/2021 143,367
Yale Catriona Chief Development Officer 09/15/2021 308,605
Young Jonathan Chief Operating Officer 09/01/2021 300,500
White William Richard Chief Financial Officer 09/01/2021 59,990
White William Richard Chief Financial Officer 09/01/2021 205,416
Cheng Andrew President & CEO 09/02/2021 418,075
Yale Catriona Chief Development Officer 08/16/2021 187,900
White William Richard Chief Financial Officer 08/02/2021 31,127
White William Richard Chief Financial Officer 08/02/2021 97,835
Cheng Andrew President & CEO 08/03/2021 364,577
Yale Catriona Chief Development Officer 07/15/2021 209,044
Young Jonathan Chief Operating Officer 07/15/2021 5,535
White William Richard Chief Financial Officer 07/06/2021 45,558
White William Richard Chief Financial Officer 07/06/2021 159,380
Cheng Andrew President & CEO 07/02/2021 433,650
Bitterman Kevin Director 06/01/2021 459,611
Young Jonathan Chief Operating Officer 04/01/2021 87,828
White William Richard Chief Financial Officer 04/01/2021 350,500
White William Richard Chief Financial Officer 04/01/2021 1,432,166
Young Jonathan Chief Operating Officer 03/01/2021 93,112
Young Jonathan Chief Operating Officer 02/01/2021 89,321
Cheng Andrew President & CEO 01/07/2021 12,300
Young Jonathan Chief Operating Officer 01/07/2021 4,613
Young Jonathan Chief Operating Officer 01/08/2021 281,200
Young Jonathan Chief Operating Officer 01/04/2021 77,399
Cheng Andrew President & CEO 12/28/2020 4,638
Cheng Andrew President & CEO 12/21/2020 6,510
Young Jonathan Chief Operating Officer 06/30/2020 21,250
White William Richard Chief Financial Officer 06/30/2020 21,250
Yale Catriona Chief Development Officer 06/30/2020 21,250
Rolph Timothy Chief Scientific Officer 06/30/2020 21,250
Cheng Andrew Chief Executive Officer 06/30/2020 21,250
Bitterman Kevin Director 10/09/2020 376,090
Apple Tree Partners IV, L.P. 10% Owner 07/10/2020 14,940,000
Harrison Seth Loring Director 07/10/2020 14,940,000
Versant Venture Capital VI, L.P. 10% Owner 01/08/2020 442,886
Versant Venture Capital VI, L.P. 10% Owner 01/07/2020 283,948
Versant Venture Capital VI, L.P. 10% Owner 01/09/2020 334,011
Versant Venture Capital VI, L.P. 10% Owner 01/06/2020 1,043,102
Versant Venture Capital VI, L.P. 10% Owner 01/03/2020 61,485
Versant Venture Capital VI, L.P. 10% Owner 01/02/2020 322,685
venBio Global Strategic Fund II L.P. 10% Owner 07/06/2020 155,721
venBio Global Strategic Fund II L.P. 10% Owner 07/02/2020 127,805
venBio Global Strategic Fund II L.P. 10% Owner 07/01/2020 3,723,010
Graham G. Walmsley Director 03/30/2020 43,295
Young Jonathan Chief Operating Officer 03/13/2020 6,837
Rolph Timothy Chief Scientific Officer 03/12/2020 30,515
venBio Global Strategic Fund II L.P. 10% Owner 03/06/2020 42,831
venBio Global Strategic Fund II L.P. 10% Owner 03/05/2020 200,011
venBio Global Strategic Fund II L.P. 10% Owner 03/04/2020 848,766
venBio Global Strategic Fund II L.P. 10% Owner 02/28/2020 108,652
venBio Global Strategic Fund II L.P. 10% Owner 03/03/2020 147,199
venBio Global Strategic Fund II L.P. 10% Owner 03/02/2020 237,459
venBio Global Strategic Fund II L.P. 10% Owner 02/27/2020 40,144
venBio Global Strategic Fund II L.P. 10% Owner 02/26/2020 56,615
venBio Global Strategic Fund II L.P. 10% Owner 02/25/2020 37,876
venBio Global Strategic Fund II L.P. 10% Owner 02/11/2020 59,068
venBio Global Strategic Fund II L.P. 10% Owner 02/10/2020 212,168
venBio Global Strategic Fund II L.P. 10% Owner 02/12/2020 163
venBio Global Strategic Fund II L.P. 10% Owner 02/06/2020 164,955
venBio Global Strategic Fund II L.P. 10% Owner 02/05/2020 743,548
venBio Global Strategic Fund II L.P. 10% Owner 02/04/2020 1,378,179
Versant Venture Capital VI, L.P. 10% Owner 01/17/2020 223,059
Versant Venture Capital VI, L.P. 10% Owner 01/16/2020 443,483
Versant Venture Capital VI, L.P. 10% Owner 01/21/2020 575,861
Versant Venture Capital VI, L.P. 10% Owner 01/10/2020 388,794
Versant Venture Capital VI, L.P. 10% Owner 01/15/2020 148,192
Versant Venture Capital VI, L.P. 10% Owner 01/14/2020 246,140
Versant Venture Capital VI, L.P. 10% Owner 01/13/2020 235,445
venBio Global Strategic Fund II L.P. 10% Owner 01/13/2020 9,993,620
Young Jonathan Chief Operating Officer 01/10/2020 23,928
venBio Global Strategic Fund II L.P. 10% Owner 01/08/2020 311,355
venBio Global Strategic Fund II L.P. 10% Owner 01/08/2020 311,355
Versant Venture Capital VI, L.P. 10% Owner 01/09/2020 334,011
Versant Venture Capital VI, L.P. 10% Owner 01/08/2020 442,886
Versant Venture Capital VI, L.P. 10% Owner 01/07/2020 283,948
venBio Global Strategic Fund II L.P. 10% Owner 01/07/2020 625,149
venBio Global Strategic Fund II L.P. 10% Owner 01/06/2020 829,381
Versant Venture Capital VI, L.P. 10% Owner 01/03/2020 61,485
Versant Venture Capital VI, L.P. 10% Owner 01/02/2020 322,685
Versant Venture Capital VI, L.P. 10% Owner 01/06/2020 1,043,102
venBio Global Strategic Fund II L.P. 10% Owner 01/03/2020 241,214
venBio Global Strategic Fund II L.P. 10% Owner 01/02/2020 458,507
Cheng Andrew President & CEO 12/31/2019 19,338
Yale Catriona Chief Development Officer 12/31/2019 19,338
White William Richard Chief Financial Officer 12/31/2019 19,338
venBio Global Strategic Fund II L.P. 10% Owner 12/31/2019 343,259
Versant Venture Capital VI, L.P. 10% Owner 12/27/2019 750,920
Versant Venture Capital VI, L.P. 10% Owner 12/31/2019 404,020
Versant Venture Capital VI, L.P. 10% Owner 12/30/2019 8,266,234
Versant Venture Capital VI, L.P. 10% Owner 12/31/2019 404,020
Versant Venture Capital VI, L.P. 10% Owner 12/30/2019 8,266,234
Versant Venture Capital VI, L.P. 10% Owner 12/27/2019 750,920
Versant Venture Capital VI, L.P. 10% Owner 12/23/2019 117,135
Versant Venture Capital VI, L.P. 10% Owner 12/20/2019 367,924
Versant Venture Capital VI, L.P. 10% Owner 12/26/2019 530,528
Versant Venture Capital VI, L.P. 10% Owner 12/24/2019 34,829
Versant Venture Capital VI, L.P. 10% Owner 12/18/2019 39,390
Versant Venture Capital VI, L.P. 10% Owner 12/17/2019 149,807
Bitterman Kevin Director 06/24/2019 4,320,000
Atlas Venture Fund XI, L.P. 10% Owner 06/24/2019 4,320,000
Royston Aaron Director 06/24/2019 4,000,000
Versant Venture Capital VI, L.P. 10% Owner 06/24/2019 6,400,000
Harrison Seth Loring Director 06/24/2019 14,400,000
Apple Tree Partners IV, L.P. 10% Owner 06/24/2019 14,400,000
venBio Global Strategic Fund II L.P. 10% Owner 06/24/2019 4,000,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2022
09/30/2021
0.57%
2Q
03/31/2022
06/30/2021
0.65%
3Q
03/31/2022
03/31/2021
0.75%
4Q
03/31/2022
12/31/2020
11.26%
5Q
03/31/2022
09/30/2020
15.22%
6Q
03/31/2022
06/30/2020
22.61%
7Q
03/31/2022
03/31/2020
22.83%
8Q
Load More

Period of Report: 03/31/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2021
0.57%
2Q
06/30/2021
0.65%
3Q
03/31/2021
0.75%
4Q
12/31/2020
11.26%
5Q
09/30/2020
15.22%
6Q
06/30/2020
22.61%
7Q
03/31/2020
22.83%
8Q
Load More